Severe pre-eclampsia far from term: How to manage the fetus-mother conflict;La pre-eclampsie severe precoce: Comment gerer le conflit d'interet foeto-maternel

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 29, Issue 3, 2000, Pages 230-233

  Magnin, G ^a   Vequeau Goua, V ^a   Pourrat, O ^a   Pierre, F ^a  

^a University of Poitiers   (France)

Author keywords

Corticosteroids; HELLP syndrome; Severe pre eclampsia

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; CLONAZEPAM; DEXAMETHASONE SODIUM PHOSPHATE; LABETALOL; NICARDIPINE; GLUCOCORTICOID;

CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FETUS; HELLP SYNDROME; HUMAN; MOTHER; PREECLAMPSIA; PREGNANCY TERMINATION; PREMATURITY; THROMBOCYTE COUNT; ADULT; ARTICLE; CESAREAN SECTION; GESTATIONAL AGE; NEWBORN; PREGNANCY;

ADULT; CESAREAN SECTION; FEMALE; GESTATIONAL AGE; GLUCOCORTICOIDS; HELLP SYNDROME; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; PLATELET COUNT; PREGNANCY;

EID: 0034028016     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Sibai BM, Taslimi MM, El-Nazer A, Amon E, Mabie BC, Ryan GM. Maternel-perinatal outcome associated with the syndrome for hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986; 155: 501-9.
2. Martin JN, Perry KG, Miles JF, Blake PG, Magann EF, Roberts WE, Martin RW. The interrelationship of eclampsia, HELLP syndrome, and prematurity: cofactors for significant maternal and perinatal risk. Br J Obstet Gynecol 1993; 100: 1095-100.
3. Sibai BM, Akl S, Fairlie F, Moretti M. A protocol for managing severe preeclampsia in the second trimester. Am J Obstet Gynecol 1990; 163: 733-8.
4. Thiagarajah S, Bourgeois J, Harbert GM, Caudle MR. Am J Obstet Gynecol 1984; 150: 1.
5. Magann EF, Bass D, Chauhan SP, Sullivan DL, Martin RW, Martin JN. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994; 171: 1148-53.
6. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gyneocol 1993; 169: 1000-6.
7. Isler CM, Rinehart BK, Terrone DA, Martin RW, Magann EF, Martin JN. Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1999; 181: 924-8.
8. Martin JN, Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of servere preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 1999; 180: 1373-84.
9. Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1996; 175: 460-4.
10. Abramovici D, Friedman SA, Mercer BM, Audibert F, Kao L, Sibai BM. Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter? Am J Obstet Gynecol 1999; 180: 221-5.
11. Odendal HJ, Pattinson RC, Barn R, Grove D, Kotze TJ. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks gestation: a randomized controlled trial. Obstet Gynecol 1990; 76: 1070-5.
12. Visser W, Wallenburg HCS. Temporising management of severe pre-eclampsia with and without the HELLP syndrome. Br J Obstet Gynecol 1995; 102: 111-7.
13. Van Pampus MG, Wolf H, Westengerg SM, Van Der Post JAM, Bonsel GJ, Treffers PE. Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with preeclampsia without HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 1998; 76: 31-6.
14. Martin JN, Perry KG, Blake PG, May WA, Moore A, Robinette L. Better maternel outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome. Am J Obstet Gynecol 1997; 177: 1011-7.
15. Dreyfus M, Tissier I, Ndocko MA, Denoual I, Baldauf JJ, Ritter J. Corticosteroid therapy for conservative management in marginally-viable pregnancy complicated by HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 1999; 85: 233-4.
16. Tompkins MJ, Thiagarajah S. HELLP (hemolysis, elevated liver enzymes, and low platelet count: syndrome, the benefit of corticosteroids. Am J Obstet Gynecol 1999; 181: 304-9.